New ALS discovery: scientists reverse protein clumping involved in neurodegenerative conditions

New ALS discovery: scientists reverse protein clumping involved in neurodegenerative conditions
By countering the tendency of the protein SOD1 to clump in motor neurons, researchers at the UNC School of Medicine find a way to protect neurons from toxic effects in lab experiments.

http://news.unchealthcare.org/news/2016/september/scientists-stabilize-faulty-als-protein-find-new-leads-for-drug-discovery


Comments

Post a Comment

Popular posts from this blog

First New Drug for Liver Cancer in a Decade: Regorafenib

The US Food and Drug Administration (FDA) has expanded the indication for regorafenib ( Stivarga , Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib ( Nexavar , Bayer). Expansion of regorafenib's indication marks the first FDA-approved treatment for a liver cancer in almost a decade! Medscape article: http://www.medscape.com/viewarticle/879216?src=soc_fb_170427_mscpedt_news_onc_livercancer
Read more